PUBLISHER: Grand View Research | PRODUCT CODE: 1841976
PUBLISHER: Grand View Research | PRODUCT CODE: 1841976
The global veterinary clinical chemistry diagnostics market size was estimated at USD 2.26 billion in 2024 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 8.69% from 2025 to 2033. The industry is primarily driven by the rising prevalence of chronic and infectious diseases in companion and livestock animals, increasing pet ownership coupled with growing humanization of pets, and higher demand for early and accurate disease detection to improve treatment outcomes.
Advancements in diagnostic technologies, including point-of-care analyzers and automated chemistry systems, enhance accessibility and efficiency in veterinary clinics and reference laboratories. Additionally, the market is being propelled by the launch of advanced diagnostics, including AI-powered and multi-application platforms, which enhance rapid in-clinic decision-making, streamline workflows, and improve diagnostic accuracy. These technologies support earlier disease detection, better treatment outcomes, and higher pet owner compliance, fueling demand for immediate and reliable veterinary diagnostics. For instance, in January 2024, Zoetis expanded its Vetscan Imagyst platform and include AI-powered Urine Sediment Analysis, that enabled veterinarians to perform accurate and fast urinalysis at the point of care. This advancement helps veterinarians work more efficiently and make quicker treatment decisions. With AI-powered tools becoming more common in veterinary care, point-of-care testing is growing rapidly, making diagnostics easier to use, faster, and more effective for managing pets' everyday health.
Moreover, with the growing need for accurate and timely diagnostic solutions in animal health, Thermo Scientific has launched the Indiko and Indiko Plus clinical chemistry analyzers for mid-sized veterinary clinics and laboratories. These compact, fully automated, random-access bench-top systems deliver efficient workflows and high-quality results, enabling veterinarians to conduct precise and rapid pet sample testing. The wider availability of these tests is expected to boost the veterinary clinical chemistry diagnostics market by making diagnostics faster, more efficient, and more accurate. This helps veterinarians make better treatment decisions while meeting the growing demand for advanced, reliable, and easy-to-access diagnostic tools in animal care.
In addition, a July 2024 article from Cormay Diagnostics noted that biochemistry tests are playing an increasingly important role in preventive veterinary care, helping vets spot health problems early and keep track of an animal's overall well-being. As the demand for quick and reliable veterinary diagnostics grows, these tests have become essential for understanding organ function, overall metabolism, and disease progress. They allow vets to build customized health profiles for each animal-whether for routine care or before a medical procedure-leading to more accurate diagnoses and treatment plans tailored to the individual pet. The flexibility and rising importance of biochemistry testing are helping drive growth in the veterinary clinical chemistry diagnostics market, as more clinics adopt advanced tools to support preventive care, work more efficiently, and provide better health outcomes for animals.
Global Veterinary Clinical Chemistry Diagnostics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary clinical chemistry diagnostics market report based on animal type, test type, sample type, end use, and region.